Oncological Outcomes of Different Managements of the Distal Ureter in Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma [0.03%]
根治性肾输尿管全长切除中不同远端输尿管处理方式的肿瘤学结局分析
Hongda Zhao,Kang Liu,Chi-Fai Ng et al.
Hongda Zhao et al.
Background: The optimal management of the distal ureter and bladder cuff during radical nephroureterectomy (RNU) for patients with upper tract urothelial carcinoma (UTUC) is uncertain. Endoscopic techniques are less invas...
Think Twice Before You Continue Long-term FU in Localised nccRCC after Surgery [0.03%]
转移性肾癌术后长期服用TKI的患者需谨慎减药停药
Patricia J Zondervan,Luuk T de Haan,Axel Bex
Patricia J Zondervan
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process [0.03%]
欧洲肿瘤研究与治疗组织膀胱癌相关生活质量模块的更新：开发过程的第1-2阶段
Elke Rammant,Louis Fox,Silva De Padova et al.
Elke Rammant et al.
Background and objective: To determine whether the existing European Organisation for Research and Treatment of Cancer (EORTC) QLQ-NMIBC24 and QLQ-BLM30 modules remain fit for purpose and to assess health-related quality ...
Robotics Is Not Important Because It Is Robotic: Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111-15 [0.03%]
机器人技术并不重要 因为它是“机器人”：来信回复Jeremy Y. Teoh、Francesco M. Bracco、Julius H. Wong等。VIABLE试验第一阶段的一种新型经尿道机器人平台 用于整块切除膀胱肿瘤：结果。Eur Urol Oncol 2026;86:111-15
Selçuk Güven,Selim Soyturk,Thomas Herrmann
Selçuk Güven
Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non-muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study [0.03%]
一项国际多中心回顾性研究：对非肌层浸润性膀胱尿路上皮癌BCG治疗失败的欧洲泌尿外科协会定义的个体患者数据验证
P Gontero,F Soria,M Babjuk et al.
P Gontero et al.
Background: In non-muscle-invasive bladder cancer (NMIBC), the occurrence of a high-grade (HG) recurrence following Bacillus Calmette-Guérin (BCG) treatment identifies a disease category that is associated with a particu...
The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysis [0.03%]
前列腺根治术后生化复发患者行前列腺特异性膜抗原正电子发射断层扫描检查的诊断作用：系统评价和Meta分析
Donato Cannoletta,Elio Mazzone,Francesco Di Bello et al.
Donato Cannoletta et al.
Background and objective: Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is increasingly used for prostate cancer staging. However, the diagnostic role of molecular imaging for patients with ...
Baseline Frailty, Treatment Intensity, and Clinical Outcomes Among Older Adults with Locally-advanced Prostate Cancer [0.03%]
基线脆弱性、治疗强度和局部晚期前列腺癌老年患者的临床结局关系研究
Agustin Perez-Londono,Jamil Almohtasib,Sumedh Kaul et al.
Agustin Perez-Londono et al.
Background and objective: The addition of prostate radiation (RT) to androgen deprivation therapy (ADT) improves oncologic outcomes in patients with locally-advanced prostate cancer (PCa). However, this approach remains u...
Diagnostic Accuracy of Liquid-Based Biomarkers for Detecting and Risk Stratifying Upper Tract Urothelial Cancers: A Diagnostic Test Systematic Review by the EAU Guidelines UTUC Panel [0.03%]
欧洲泌尿外科协会UTUC指南小组上尿路尿路上皮癌检测和风险分层液体生物标志物诊断准确性系统评价
Bhavan Prasad Rai,Karthik Rajan,Prabhakar Rajan et al.
Bhavan Prasad Rai et al.
Objectives: Liquid-based biomarkers (LBBs), derived from urine and blood, are gaining attention in the management of upper tract urothelial carcinoma (UTUC) as potential tools to overcome limitations of current diagnostic...
Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials [0.03%]
中危非肌层浸润性膀胱癌行辅助治疗的疗效：四项随机对照试验的汇总分析
Wei Shen Tan,Ashish M Kamat,Rebecca Lewis et al.
Wei Shen Tan et al.
Background and objective: Historic prediction models overestimate the risk of recurrence and progression for intermediate risk (IR) non-muscle-invasive bladder cancer (NMIBC). We report outcomes for patients with IR-NMIBC...
Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis [0.03%]
非肌层浸润性膀胱癌患者新辅助腔内治疗的系统评价和meta分析
Paolo Zaurito,Pietro Scilipoti,Alfonso Santangelo et al.
Paolo Zaurito et al.
Patients with non-muscle-invasive bladder cancer (NMIBC) have a significant risk of recurrence after trans-urethral resection of bladder tumor (TURBT). The use of neoadjuvant intravesical therapy prior to TURBT has been investigated previou...